92 related articles for article (PubMed ID: 2629075)
1. [Regional hemorheological-hemodynamic correlations in paraproteinemia syndromes].
Ansani L; Mele D; Vaccari M; Spanedda R; Scapoli G; Musacci G; Longhini C
Ric Clin Lab; 1989; 19 Suppl 1():141-5. PubMed ID: 2629075
[No Abstract] [Full Text] [Related]
2. [The morphological picture and viscosity of serum in patients with paraproteinemia].
Potekhina IuP; Kotova OV; Nistratova MP; Lazareva VA
Klin Lab Diagn; 2005 Jul; (7):38-41. PubMed ID: 16127993
[No Abstract] [Full Text] [Related]
3. [Clinical and biohumoral significance of plasma viscosity in patients with paraproteinemia without clinical hyperviscosity syndrome. A study of 40 cases (author's transl)].
Barbarano L; Rossi AF; Vendrami R; Van Westerhout G; Sala G; Canesi BA
Haematologica; 1981 Aug; 66(4):452-60. PubMed ID: 6797880
[No Abstract] [Full Text] [Related]
4. Viscosity of paraproteinemic sera.
Tichý M
Acta Medica (Hradec Kralove); 1996; 39(1):41-3. PubMed ID: 9106390
[TBL] [Abstract][Full Text] [Related]
5. Impaired skin microcirculation and blood rheology in patients with monoclonal gammapathy.
Szulkowska E; Sułek K; Kraj M; Budziszewska K; Zygocki K
Clin Hemorheol Microcirc; 1999; 21(2):105-12. PubMed ID: 10599594
[TBL] [Abstract][Full Text] [Related]
6. Effects of doxazosin on hemorheological, hemodynamic and lipid parameters in patients with essential hypertension.
Toth K; Nemes J; Czopf L; Kapronczay P; Kesmarky G; Juricskay I
Clin Hemorheol Microcirc; 1999; 20(1):57-61. PubMed ID: 11185685
[TBL] [Abstract][Full Text] [Related]
7. Hemorheological and hemodynamic parameters in patients with essential hypertension and their modification by alpha-1 inhibitor drug treatment.
Toth K; Kesmarky G; Vekasi J; Nemes J; Czopf L; Kapronczay P; Halmosi R; Papp E; Juricskay I
Clin Hemorheol Microcirc; 1999; 21(3-4):209-16. PubMed ID: 10711745
[TBL] [Abstract][Full Text] [Related]
8. [Regional hemorheological effects induced by muscular exertion in peripheral obstructive arteriopathy. II].
Perego MA; Sergio G; Espureo M; Giunti P; Francisci A; La Penna F; Artale F
Minerva Cardioangiol; 1981; 29(7-8):375-82. PubMed ID: 7279238
[No Abstract] [Full Text] [Related]
9. [Lymphosarcoma with paraproteinemia].
Volkova MA; Reĭzinger MA; Kruglova GV; Probatova NA
Ter Arkh; 1980; 52(2):107-11. PubMed ID: 6892857
[No Abstract] [Full Text] [Related]
10. [Paraproteinemia and its possible prognostic significance in chronic myelosis].
Tishchenko LM; Guseva SA; Sarnitskiĭ IP
Vrach Delo; 1984 Jul; (7):105-7. PubMed ID: 6591628
[No Abstract] [Full Text] [Related]
11. Hemorheological parameters in coronary artery disease.
Kesmarky G; Toth K; Habon L; Vajda G; Juricskay I
Clin Hemorheol Microcirc; 1998 Jul; 18(4):245-51. PubMed ID: 9741664
[TBL] [Abstract][Full Text] [Related]
12. [Hyperfibrinolysis syndrome in paraproteinemia (IgG)].
Egbring R; Klingemann HG; Heimburger N; Karges HE
Med Welt; 1981 Sep; 32(39):1427-30. PubMed ID: 7300644
[No Abstract] [Full Text] [Related]
13. [Biclonal paraproteinemia: macroglobulinemia-myeloma].
Rabago Torre L; Velo Bellver JL; Clemente Ricote G; López de la Riva M; Alcalá-Santaella R
Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):50-5. PubMed ID: 6813927
[No Abstract] [Full Text] [Related]
14. Influence of Bence-Jones proteins, hyperviscosity, hypercalcemia, hyperuricemia and dehydration on development of renal changes in plasma cell dyscrasias.
Lenert P; Drazen F; Tepavcević P; Pejin D; Curić S; Ilić V; Uzurov V; Popowić S; Zupunski A; Djisalov M
Przegl Lek; 1985; 42(4):384-6. PubMed ID: 4048525
[No Abstract] [Full Text] [Related]
15. [Microrheologic behavior of plasma cell dyscrasia].
Volger E; Emmerich B; Schmid-Schönbein H; Gallasch G
Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1616-9. PubMed ID: 1030061
[No Abstract] [Full Text] [Related]
16. [Hemorheological disorders in patients with sudden deafness].
Zheng S; Jiang R; Fan M
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Mar; 14(1):11-4, 57. PubMed ID: 9817657
[TBL] [Abstract][Full Text] [Related]
17. Hemorheological and hemodynamic changes in predialysis patients after normalization of hemoglobin with epoetin-alpha.
Furuland H; Linde T; Sandhagen B; Andrén B; Wikström B; Danielson BG
Scand J Urol Nephrol; 2005; 39(5):399-404. PubMed ID: 16257842
[TBL] [Abstract][Full Text] [Related]
18. [Hemodynamic changes in primary arterial hypertension and various rheological parameters of the blood].
Wysocki M; Grajek S; Paradowski S; Kozłowska F
Kardiol Pol; 1985; 28(11):698-706. PubMed ID: 3835372
[No Abstract] [Full Text] [Related]
19. Treatment of hyperviscosity syndrome in the patients with plasma cell dyscrasias.
Kes P; Pecanić Z; Getaldić B; Ratković-Gusić I
Acta Med Croatica; 1996; 50(4-5):173-7. PubMed ID: 9046114
[TBL] [Abstract][Full Text] [Related]
20. Relationship between blood viscosity and infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Cecchi E; Liotta AA; Gori AM; Valente S; Giglioli C; Lazzeri C; Sofi F; Gensini GF; Abbate R; Mannini L
Int J Cardiol; 2009 May; 134(2):189-94. PubMed ID: 18495262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
